Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 11, 2024CureusOpen Access

Confounding Factors in the Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Retained Gastric Contents in Asymptomatic Patients Undergoing Upper Gastrointestinal Endoscopy: A Retrospective Study

View Full Paper
Ask AI
Bookmark
Share

Authors

TEThomas A ElimiheleAMAnjali M MangrolaOOOluwatobi Oshomoji

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Elimihele et al. (2024) studied this question.

synapsesocial.com/papers/68e58cbfb6db643587528583https://doi.org/10.7759/cureus.69152
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study2024 · 12 citations
  2. 2Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans1997 · 820 citations
  3. 3Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD)2021 · 77 citations
  4. 4The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity2020 · 416 citations
  5. 5Association of <scp>glucagon‐like peptide</scp>‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy2023 · 146 citations